• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Transvaginal vs Laparoscopic Cuff Closure to Prevent Dehiscence

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Vaginal cuff dehiscence is estimated to be between 0.1-0.2% following open or vaginal hysterectomy
  • Some reports have suggested that minimally invasive procedures may result in increased risk for dehiscence
  • Previous literature has reported that a transvaginal approach to vaginal cuff closure at the end of an otherwise totally endoscopic hysterectomy reduces the risk of postoperative vaginal breakdown
  • Uccella et al. (AJOG, 2018) undertook an RCT to compare laparoscopic vs TV closure of the vaginal vault following laparoscopic hysterectomy

METHODS:

  • Multicentered randomized study
  • Participants: Patients undergoing total laparoscopic hysterectomy for benign indications
  • Patients received vaginal closure through either:
    • Transvaginal approach
      • Vaginal closures had a single-layer running braided and coated 0-polyglactic suture
    • Laparoscopic approach
  • Monopolar energy for colpotomy was set at 60W
  • In all cases an attempt was performed to include the posterior peritoneum in the suture
  • Laparoscopic knots were tied intracorporeally
  • 3 month follow up to identify possible vaginal cuff complications
  • Univariate and multivariable analyses were performed to identify independent predictors of vaginal cuff dehiscence after total laparoscopic hysterectomy
  • Primary outcome
    • Rate of vaginal cuff dehiscence
    • Secondary outcomes were
      • Vaginal bleeding, vaginal cuff hematoma, postoperative infection, vaginal resuturing, any reoperation, and a combined outcome defined as “any cuff complication,” including any patient with at least 1 vaginal dehiscence, vaginal hematoma, vaginal bleeding, postoperative infection, or vaginal resuturing

RESULTS:

  • Study was stopped early following interim analysis
  • 1,408 patients were enrolled in a prespecified interim analysis
    • 13 (0.9%) women did not undergo the postoperative assessment and were excluded
  • Baseline characteristics of the 1395 patients included (695 in the transvaginal group and 700 in the laparoscopic group) were similar
  • Patients in the transvaginal group had significantly higher rates of the following
    • Vaginal dehiscence: 2.7% vs 1%; odds ratio (OR) 2.78; 95% CI, 1.16–6.63 (P=.01)
    • Cuff complications: 9.8% vs 4.7%; OR 2.19; 95% CI, 1.43–3.37 (P=.0003)
  • After multivariable analysis, transvaginal closure of the vault was independently associated with higher rates of vaginal dehiscence and vaginal complications
  • Higher risk of dehiscence was also associated with premenopausal status and smoking habit

CONCLUSION:

  • Laparoscopic closure is associated with reduced risk for vaginal dehiscence, any cuff complication, vaginal bleeding, vaginal cuff hematoma, postoperative infection, need for vaginal resuture, and reintervention
  • Possible explanations for laparoscopic closure being a superior approach are
    • Performing the suture intraabdominally allows the surgeon to incorporate the peritoneum
    • Closing the gap between the vaginal mucosa and the pouch of Douglas may decrease postoperative oozing reducing hematoma risk
    • Magnification capability using laparoscopy

Learn More – Primary Sources:

Laparoscopic vs transvaginal cuff closure after total laparoscopic hysterectomy: a randomized trial by the Italian Society of Gynecologic Endoscopy

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone

Learn More >>

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Recognition, Evaluation and Treatment of Vaginal Cuff Separation
‘Opportunistic’ Salpingectomy at the Time of Hysterectomy: Risks vs Benefits
Should Fallopian Tubes Also Be Removed During Ovarian Conserving Benign Hysterectomy? 

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site